Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis

Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis

US Patent 11518803 · Granted Dec 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-alpha-synuclein antibodies2025
Anti-alpha-synuclein antibodies2025
Anti-FcRn antibodies2025
Anti-FcRn antibodies2025
Antibody molecules which bind CD222025
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders2025
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders2025
Methods of use of anti-TNFα antibodies2024
Tau-binding antibodies2023
Antibody molecules which bind CD452023
Method of identifying potential inhibitors of APO TNFα trimers2023
Fused imidazole derivatives as IL-17 modulators2022